3-hydroxyflavone has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Çiçek, SS; Galarza Pérez, M; Jöhrer, K; Kircher, B | 1 |
| Chen, CY; Jang, KY; Jeong, SJ; Jung, JH; Kim, JH; Kim, SH; Koh, W | 1 |
2 other study(ies) available for 3-hydroxyflavone and Multiple Myeloma
| Article | Year |
|---|---|
Flavones, Flavonols, Lignans, and Caffeic Acid Derivatives from
Topics: Cell Line, Tumor; Flavones; Flavonols; Lamiaceae; Leukemia, Myeloid, Acute; Lignans; Multiple Myeloma; Phenols | 2022 |
Activation of reactive oxygen species/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Flavonoids; Flavonols; Humans; Multiple Myeloma; Reactive Oxygen Species; Signal Transduction | 2012 |